You have 9 free searches left this month | for more free features.

Dyslipidaemia

Showing 1 - 25 of 629

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers, Dyslipidaemia Trial in Cypress (NNC0491-6075, Placebo)

Recruiting
  • Healthy Volunteers
  • Dyslipidaemia
  • Cypress, California
    Novo Nordisk Investigational Site
Aug 8, 2023

Fixed-dose Combination Rosuvastatin/Ezetimibe for Dyslipidaemia

Completed
  • Dyslipidemias
  • Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose
  • Mexico City, Mexico
    Laboratorio Silanes, S.A. de C.V.
Feb 28, 2022

Sleep Apnea, Dyslipidaemia Trial in Alcalá de Henares (device, behavioral, other)

Suspended
  • Sleep Apnea
  • Dyslipidaemia
  • Continuous positive airway pressure
  • +2 more
  • Alcalá de Henares, Madrid, Spain
    Hospital Universitario Príncipe de Asturias
Feb 11, 2021

Dyslipidemia Associated With Type II Diabetes Trial in Mexico City (Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose,

Recruiting
  • Dyslipidemia Associated With Type II Diabetes Mellitus
  • Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose
  • Atorvastatin (Lipitor ®)
  • Mexico City, Mexico
    Laboratorio Silanes, S.A. de C.V.
Feb 28, 2022

Dyslipidaemia Trial in Denmark, Slovakia, United States (AZD8233, Placebo)

Completed
  • Dyslipidaemia
  • Roseville, California
  • +18 more
Nov 7, 2022

Lipid Profile and Diabetes Mellitus in People With HIV

Recruiting
  • HIV Infections
  • +3 more
    • Vienna, Austria
      Schalk:Pichler Gruppenpraxis
    Apr 4, 2022

    Relation Between NAFLD and BM DENSITY

    Not yet recruiting
    • NAFLD
    • Osteoporosis
    • Fibroscan
    • (no location specified)
    Sep 14, 2023

    Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

    Not yet recruiting
    • Lupus Nephritis
    • Chronic Kidney Diseases
    • Dapagliflozin 10mg Tab
    • Standard maintenance therapy
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 24, 2023

    Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

    Not yet recruiting
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Bempedoic acid and/or its fixed dose combination with ezetimibe
    • (no location specified)
    Mar 23, 2023

    Hypertension, Dyslipidemia Trial in Canada, United Kingdom (Amlodipine/Atorvastatin)

    Completed
    • Hypertension
    • Dyslipidemia
    • Calgary, Alberta, Canada
    • +125 more
    Jan 26, 2021

    Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With

    Active, not recruiting
    • COVID-19 Pneumonia
    • +4 more
      • Faro, Portugal
      • +1 more
      Apr 26, 2023

      Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated

      Recruiting
      • Type 2 Diabetes Mellitus in Obese
      • Dyslipidemia Associated With Type II Diabetes Mellitus
      • Chinese herb medicine
      • Beijing, Beijing, China
        Guang'anmen Hospital, China Academy of Chinese Medical Sciences
      Apr 6, 2022

      Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis

      Recruiting
      • Type2diabetes
      • Clinical Examination
      • Delhi, India
        Fortis CDOC Hospital
      Jul 11, 2023

      Pollutants in Atherosclerotic Plaque and Cardiovascular Events

      Recruiting
      • Atherosclerosis
      • analysis of carotid atherosclerotic plaque
      • Naples, Italy
        Celestino Sardu
      Jun 12, 2023

      Acute Coronary Syndrome, Myocardial Infarction, Ischemic Stroke Trial in Dudley (Decision Support System (DSS))

      Recruiting
      • Acute Coronary Syndrome
      • +2 more
      • Decision Support System (DSS)
      • Dudley, West Midlands, United Kingdom
        Russell's Hall Hospital
      Apr 25, 2023

      Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

      Not yet recruiting
      • Hypercholesterolemia
      • +3 more
      • Cambridge, United Kingdom
        University of Cambridge
      Jan 13, 2023

      Patterns With Use of Saxenda® in Real-life Settings in

      Enrolling by invitation
      • Obesity or Overweight
      • Soeborg, Denmark
        Novo Nordisk Investigational Site
      Dec 15, 2021

      Diabetes Trial in Beijing (Berberine Chloride, Placebo)

      Completed
      • Diabetes Mellitus
      • Berberine Chloride
      • Placebo
      • Beijing, Beijing, China
      • +1 more
      Jul 14, 2023

      Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)

      Completed
      • Hyperlipidemia
      • Cholesfytol NG®) supplement
      • Leuven, Belgium
        Cliniques universitaires St-Luc and Institut de Recherche Expéri
      Aug 18, 2023

      Cardiovascular Disease, Stroke, Primary Prevention Trial in Yibin (The strategic use of messages in risk communication)

      Completed
      • Cardiovascular Disease
      • +2 more
      • The strategic use of messages in risk communication
      • Yibin, Sichuan, China
        Health center of Sipo town
      Mar 9, 2022

      Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman

      Not yet recruiting
      • Dyslipidemias
      • Atherosclerotic Cardiovascular Disease
        • Amman, Jordan
        • +1 more
        Nov 23, 2022

        Coronary Heart Disease, Diabetes, Type 2, Periodontitis Trial in Denizli (clinical periodontal measurements, CAVI measurements)

        Completed
        • Coronary Heart Disease
        • +3 more
        • clinical periodontal measurements
        • CAVI measurements
        • Denizli, Turkey
          Pamukkale University Faculty of Dentistry
        May 10, 2023

        Diabetes Mellitus and HIV Study in Mwanza

        Active, not recruiting
        • Diabetes Mellitus
        • HIV/AIDS
          • Mwanza, Mwanza Region, Tanzania
            NIMR Research Clinic
          Jun 28, 2021

          Rectal Cancer, Rectum Tumor Trial (Transanal local excision)

          Not yet recruiting
          • Rectal Cancer
          • Rectum Neoplasm
          • Transanal local excision
          • (no location specified)
          Jun 22, 2023

          NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

          Not yet recruiting
          • Nonalcoholic Fatty Liver Disease
          • +3 more
            • (no location specified)
            Apr 18, 2022